Tau Associated Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Neurons with tau pathology represent the primary cellular correlate of cognitive decline in Alzheimer's disease (AD). Hyperphosphorylated tau forms neurofibrillary tangles (NFTs) that disrupt neuronal function and lead to cell death.
- Microtubule binding: Tau stabilizes axonal microtubules
- Axonal transport: Facilitates vesicle and organelle trafficking
- Neuronal polarity: Maintains axonal identity
- Synaptic function: Modulates postsynaptic density
- Hyperphosphorylation: Abnormal phosphorylation reduces microtubule binding
- Conformational change: AD-tau adopts pathogenic beta-sheet
- Oligomer formation: Soluble toxic oligomers accumulate
- Fibril assembly: Paired helical filaments (PHFs) form NFTs
- Earliest involvement: Grid cells affected first (Braak stage I-II)
- Episodic memory: ECII→CA1 pathway disrupted early
- Functional consequence: Memory encoding deficits
- NFT burden: High density of tangles
- Synaptic loss: Correlates with cognitive impairment
- Circuit dysfunction: Disrupts hippocampal circuitry
- Connectivity: Pivotal for corticocortical communication
- Tau propagation: Serve as hub for spread
- Dysfunction: Contributes to cortical disconnection
- Microtubule destabilization: Axonal transport deficits
- Synaptic dysfunction: Pre- and postsynaptic impairment
- Organelle trafficking: Mitochondrial and lysosomal dysfunction
- Oligomer toxicity: Soluble species are most toxic
- ER stress: UPR activation
- Oxidative stress: ROS accumulation
- Neuroinflammation: Glial activation
- Immunotherapies: Anti-tau antibodies (phase 2/3)
- Small molecule inhibitors: Tau aggregation inhibitors
- Oligomer modulators: Stabilize native conformation
- Kinase inhibitors: Target upstream kinases (GSK-3β, CDK5)
Tau Associated Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Tau Associated Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Kosik et al., Tau biology and therapy (2024)
- Mudher et al., Tau function and dysfunction (2023)
- Braak & Del Tredici, NFT staging (2022)
- Wang & Mandelkow, Tau post-translational modifications (2020)
- Schoonenboom et al., Tau immunotherapy trials (2024)